Literature DB >> 19766268

Polyunsaturated fatty acids effect on serum triglycerides concentration in the presence of metabolic syndrome components. The Alaska-Siberia Project.

Juan C Lopez-Alvarenga1, Sven O E Ebbesson, Lars O E Ebbesson, M Elizabeth Tejero, V Saroja Voruganti, Anthony G Comuzzie.   

Abstract

Serum fatty acids (FAs) have wide effects on metabolism: Serum saturated fatty acids (SFAs) increase triglyceride (TG) levels in plasma, whereas polyunsaturated fatty acids (PUFAs) reduce them. Traditionally, Eskimos have a high consumption of omega-3 fatty acids (omega3 FAs); but the Westernization of their food habits has increased their dietary SFAs, partly reflected in their serum concentrations. We studied the joint effect of serum SFAs and PUFAs on circulating levels of TGs in the presence of metabolic syndrome components. We included 212 men and 240 women (age, 47.9 +/- 15.7 years; body mass index [BMI], 26.9 +/- 5.3) from 4 villages located in Alaska for a cross-sectional study. Generalized linear models were used to build surface responses of TG as functions of SFAs and PUFAs measured in blood samples adjusting by sex, BMI, and village. The effects of individual FAs were assessed by multiple linear regression analysis, and partial correlations (r) were calculated. The most important predictors for TG levels were glucose tolerance (r = 0.116, P = .018) and BMI (r = 0.42, P < .001). Triglyceride concentration showed negative associations with 20:3omega6 (r = -0.16, P = .001), 20:4omega6 (r = -0.14, P = .005), 20:5omega3 (r = -0.17, P < .001), and 22:5omega3 (r = -0.26, P < .001), and positive associations with palmitic acid (r = 0.16, P < .001) and 18:3omega3 (r = 0.15, P < .001). The surface response analysis suggested that the effect of palmitic acid on TG is blunted in different degrees according to the PUFA chemical structure. The long-chain omega3, even in the presence of high levels of saturated fat, was associated with lower TG levels. Eicosapentaenoic acid (20:5omega3) had the strongest effect against palmitic acid on TG. The total FA showed moderate association with levels of TG, whereas SFA was positively associated and large-chain PUFA was negatively associated. The Westernized dietary habits among Eskimos are likely to change their metabolic profile and increase comorbidities related to metabolic disease.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19766268      PMCID: PMC2808028          DOI: 10.1016/j.metabol.2009.07.010

Source DB:  PubMed          Journal:  Metabolism        ISSN: 0026-0495            Impact factor:   8.694


  24 in total

1.  AHA Dietary Guidelines: revision 2000: A statement for healthcare professionals from the Nutrition Committee of the American Heart Association.

Authors:  R M Krauss; R H Eckel; B Howard; L J Appel; S R Daniels; R J Deckelbaum; J W Erdman; P Kris-Etherton; I J Goldberg; T A Kotchen; A H Lichtenstein; W E Mitch; R Mullis; K Robinson; J Wylie-Rosett; S St Jeor; J Suttie; D L Tribble; T L Bazzarre
Journal:  Circulation       Date:  2000-10-31       Impact factor: 29.690

2.  Diabetes and impaired glucose tolerance in three Alaskan Eskimo populations. The Alaska-Siberia Project.

Authors:  S O Ebbesson; C D Schraer; P M Risica; A I Adler; L Ebbesson; A M Mayer; E V Shubnikof; J Yeh; O T Go; D C Robbins
Journal:  Diabetes Care       Date:  1998-04       Impact factor: 19.112

3.  Serum fatty acids in postinfarction middle-aged men.

Authors:  M H Leskinen; T Solakivi; T Kunnas; H Alho; S T Nikkari
Journal:  Scand J Clin Lab Invest       Date:  2005       Impact factor: 1.713

4.  Diabetes is related to fatty acid imbalance in Eskimos.

Authors:  S O Ebbesson; J Kennish; L Ebbesson; O Go; J Yeh
Journal:  Int J Circumpolar Health       Date:  1999-04       Impact factor: 1.228

5.  Overweight and obesity among Alaskan Eskimos of the Bering Straits Region: the Alaska Siberia project.

Authors:  P M Risica; C Schraer; S O Ebbesson; E D Nobmann; B Caballero
Journal:  Int J Obes Relat Metab Disord       Date:  2000-08

6.  11beta-hydroxysteroid dehydrogenase type 1 in adipose tissue and prospective changes in body weight and insulin resistance.

Authors:  Juraj Koska; Barbora de Courten; Deborah J Wake; Saraswathy Nair; Brian R Walker; Joy C Bunt; Paska A Permana; Robert S Lindsay; P Antonio Tataranni
Journal:  Obesity (Silver Spring)       Date:  2006-09       Impact factor: 5.002

Review 7.  Etiology of the metabolic syndrome: potential role of insulin resistance, leptin resistance, and other players.

Authors:  P Zimmet; E J Boyko; G R Collier; M de Courten
Journal:  Ann N Y Acad Sci       Date:  1999-11-18       Impact factor: 5.691

Review 8.  Muscle triglycerides and mitochondrial function: possible mechanisms for the development of type 2 diabetes.

Authors:  M Roden
Journal:  Int J Obes (Lond)       Date:  2005-09       Impact factor: 5.095

9.  Subcutaneous adipose 11 beta-hydroxysteroid dehydrogenase type 1 activity and messenger ribonucleic acid levels are associated with adiposity and insulinemia in Pima Indians and Caucasians.

Authors:  Robert S Lindsay; Deborah J Wake; Saraswathy Nair; Joy Bunt; Dawn E W Livingstone; Paska A Permana; P Antonio Tataranni; Brian R Walker
Journal:  J Clin Endocrinol Metab       Date:  2003-06       Impact factor: 5.958

10.  11beta-Hydroxysteroid dehydrogenase Type 1: genetic polymorphisms are associated with Type 2 diabetes in Pima Indians independently of obesity and expression in adipocyte and muscle.

Authors:  S Nair; Y H Lee; R S Lindsay; B R Walker; P A Tataranni; C Bogardus; L J Baier; P A Permana
Journal:  Diabetologia       Date:  2004-05-20       Impact factor: 10.122

View more
  12 in total

1.  Metabolomics identifies changes in fatty acid and amino acid profiles in serum of overweight older adults following a weight loss intervention.

Authors:  A Perez-Cornago; L Brennan; I Ibero-Baraibar; H H M Hermsdorff; A O'Gorman; M A Zulet; J Alfredo Martínez
Journal:  J Physiol Biochem       Date:  2014-01-09       Impact factor: 4.158

Review 2.  Role of omega-3 fatty acids in obesity, metabolic syndrome, and cardiovascular diseases: a review of the evidence.

Authors:  Silvia Lorente-Cebrián; André G V Costa; Santiago Navas-Carretero; María Zabala; J Alfredo Martínez; María J Moreno-Aliaga
Journal:  J Physiol Biochem       Date:  2013-06-22       Impact factor: 4.158

3.  Excessive 5-year weight gain predicts metabolic syndrome development in healthy middle-aged adults.

Authors:  Yu-Cheng Lin; Jong-Dar Chen; Pau-Chung Chen
Journal:  World J Diabetes       Date:  2011-01-15

4.  A diet based on multiple functional concepts improves cardiometabolic risk parameters in healthy subjects.

Authors:  Juscelino Tovar; Anne Nilsson; Maria Johansson; Rickard Ekesbo; Ann-Margreth Aberg; Ulla Johansson; Inger Björck
Journal:  Nutr Metab (Lond)       Date:  2012-04-02       Impact factor: 4.169

5.  Genomics of post-prandial lipidomic phenotypes in the Genetics of Lipid lowering Drugs and Diet Network (GOLDN) study.

Authors:  Marguerite R Irvin; Degui Zhi; Stella Aslibekyan; Steven A Claas; Devin M Absher; Jose M Ordovas; Hemant K Tiwari; Steve Watkins; Donna K Arnett
Journal:  PLoS One       Date:  2014-06-06       Impact factor: 3.240

Review 6.  Combining pain therapy with lifestyle: the role of personalized nutrition and nutritional supplements according to the SIMPAR Feed Your Destiny approach.

Authors:  Manuela De Gregori; Carolina Muscoli; Michael E Schatman; Tiziana Stallone; Fabio Intelligente; Mariangela Rondanelli; Francesco Franceschi; Laura Isabel Arranz; Silvia Lorente-Cebrián; Maurizio Salamone; Sara Ilari; Inna Belfer; Massimo Allegri
Journal:  J Pain Res       Date:  2016-12-08       Impact factor: 3.133

7.  Influence of metabolic syndrome on the relationship between fatty acids and the selected parameters in men with benign prostatic hyperplasia.

Authors:  Katarzyna Grzesiak; Aleksandra Rył; Weronika Ratajczak; Ewa Stachowska; Iwona Rotter; Marcin Słojewski; Olimpia Sipak; Kinga Walczakiewicz; Maria Laszczyńska
Journal:  Aging (Albany NY)       Date:  2019-03-13       Impact factor: 5.682

8.  Effect of Macrotyloma uniflorum on antiobesity in rats fed with a high fat diet.

Authors:  Bharathi Vadivelu; Vijaya Anand Arumugam; Shanthi Subbarayan; Ali A Alshatwi; Rajapandiyan Krishnamoorthy
Journal:  Saudi J Biol Sci       Date:  2018-05-03       Impact factor: 4.219

Review 9.  Impact of Blood or Erythrocyte Membrane Fatty Acids for Disease Risk Prediction: Focusing on Cardiovascular Disease and Chronic Kidney Disease.

Authors:  Oh Yoen Kim; Su Mi Lee; Won Suk An
Journal:  Nutrients       Date:  2018-10-07       Impact factor: 5.717

10.  Impact of pre-diagnostic triglycerides and HDL-cholesterol on breast cancer recurrence and survival by breast cancer subtypes.

Authors:  Trygve Lofterød; Elin S Mortensen; Hawa Nalwoga; Tom Wilsgaard; Hanne Frydenberg; Terje Risberg; Anne Elise Eggen; Anne McTiernan; Sura Aziz; Erik A Wist; Andreas Stensvold; Jon B Reitan; Lars A Akslen; Inger Thune
Journal:  BMC Cancer       Date:  2018-06-15       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.